BioXyTran is a biopharmaceutical company that develops treatments for stroke and Ischemia.

Biotechnology

Health Care

Pharmaceutical

BioXyTran

BioXyTran's headquarters in Newton, MA, United States

David Platt

Adesuyi Ajayi MD

Leslie Ajayi

Michael Sheikh

Ola Soderquist

Mike Sheikh

Hana Chen-Walden

Anders N. Utter

Thomaskutty Alumparambil

Dale H. Conaway

Alben Sigamani

Avraham Mayevsky

Alan M. Hoberman

John Mabayoje

Kevin H Mayo

The Advisory Team at BioXyTran provides strategic guidance and expertise in the development of innovative biopharmaceutical treatments for stroke and ischemia. Comprising seasoned advisors and a Medical Advisory Board, the team collaborates on clinical strategies, regulatory pathways, and research priorities, ensuring alignment with the latest scientific advancements and patient needs. Their collective insights aim to enhance the company's product development efforts and optimize clinical outcomes.

Advisory Team

The Leadership Team at BioXyTran is responsible for setting the strategic direction of the company, overseeing operations, and ensuring alignment with the organization's mission to develop innovative treatments for stroke and ischemia. This team collaborates on financial planning, stakeholder communication, and overall governance to drive the company's growth and influence within the biopharmaceutical industry.

Leadership Team

BioXyTran

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

BioXyTran

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies